Fairvalue-Calculator Fairvalue-Calculator
EN DE

Nuveen Select Tax-Free Income Portfolio (NXP) Fair Value & Analysis

Financial Services · US · Market cap $900M

Price$14.25
Fair Value$2.58
Upside-81.9%
Quality87/100
Evidence: Medium Range $1.93 – $3.22

Analysis

Nuveen Select Tax-Free Income Portfolio (NXP) currently trades at $14.25, while our model-based Fair Value estimate is $2.58 — implying the stock looks roughly 81.9% overvalued today. We read business quality at 87/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Nuveen Select Tax-Free Income Portfolio is a closed-ended fixed income mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of United States. The fund invests in the investment-grade municipal securities rated Baa and BBB or better. It benchmarks the performance of its portfolio against the Standard & Poor's (S&P) National Municipal Bond Index and Lipper General and Insured Unleveraged Municipal Debt Funds Average. Nuveen Select Tax-Free Income Portfolio was formed on March 19, 1992 and is domiciled in the United States.

Open the full interactive analysis →

Similar stocks

Fondul Proprietatea SA (FP) +90% The Schiehallion Fund Limited (MNTN) +100% BlackRock, Inc (UU2) -36% Blackstone Inc (BX) -56% BH Macro Limited (BHMU) +104% Investor AB (IVSBF) +100%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.